Entering text into the input field will update the search result below
Search for Symbols, analysts, keywords

Eliem Therapeutics GAAP EPS of -$0.40

  • Eliem Therapeutics press release (NASDAQ:ELYM): Q4 GAAP EPS of -$0.40.
  • Cash, cash equivalents and marketable securities was $161.4M as of December 31, 2021.

Recommended For You

Comments

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.